Search research articles
Contact Us
Filters
Showing results (381-390 of 407) with videos related to
Page
of 41
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2006
Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma
Anne W M Lee, Stewart Y Tung, Anthony T C Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Yu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
The Lancet. Oncology
|
May 11, 2015
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard, Anne Lee, Sophie Marguet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 22, 2006
Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)
Peter M L Teo, Sing Fai Leung, Stewart Y Tung, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2020
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
E P Hui, W F Li, B B Ma, et al.
The New England Journal of Medicine
|
August 10, 2017
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K C Allen Chan, John K S Woo, Ann King, et al.
Journal of the National Cancer Institute
|
December 9, 2016
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis
Federico Rotolo, Jean-Pierre Pignon, Jean Bourhis, et al.
Cancer Treatment Reviews
|
June 28, 2026
Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck
Carlo Resteghini, Athanassios Argiris, Pierre Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Winnie Yeo, Hyun C Chung, Stephen L Chan, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 407) with videos related to
Sort By:
Page
of 41
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2006
Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma
Anne W M Lee, Stewart Y Tung, Anthony T C Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Yu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
The Lancet. Oncology
|
May 11, 2015
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard, Anne Lee, Sophie Marguet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 22, 2006
Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)
Peter M L Teo, Sing Fai Leung, Stewart Y Tung, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K C Allen Chan, Peiyong Jiang, Carol W M Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2020
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
E P Hui, W F Li, B B Ma, et al.
The New England Journal of Medicine
|
August 10, 2017
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K C Allen Chan, John K S Woo, Ann King, et al.
Journal of the National Cancer Institute
|
December 9, 2016
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis
Federico Rotolo, Jean-Pierre Pignon, Jean Bourhis, et al.
Cancer Treatment Reviews
|
June 28, 2026
Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck
Carlo Resteghini, Athanassios Argiris, Pierre Blanchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Winnie Yeo, Hyun C Chung, Stephen L Chan, et al.
Page
of 41